Group Leader
Chaysavanh Manichanh
PhD Students
Zixuan Xie, Zaida Soler, Luis Mayorga, Gerard Serrano, Silvia Cuenca, Estela Rosell
Nursing and Technical Staff
Sara Vega, Alejandra Gonzalez, Marc Pons, Andrea Martinez
6
PUBLICATIONS
83.3%
%Q1
32
IMPACT FACTOR
5.35
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Cuenca S, Soler Z, Serrano-Gómez G, Xie Z, Barquinero J, Roca J, Sirvent JM, Manichanh C.
Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients
Int J Mol Sci. 2022 Dec 13;23(24):15808
DOI: doi: 10.3390/ijms232415808
IF: 6.208
Vargas M, Yañez F, Elias A, Bernabeu A, Goya M, Xie Z, Farrás A, Sánchez O,
Soler Z, Blasquez C, Valle L, Olivella A, Muñoz B, Brik M, Carreras E, Manichanh C
Cervical pessary and cerclage placement for preterm birth prevention and cervicovaginal microbiome changes
Acta Obstet Gynecol Scand. 2022 Dec;101(12):1403-1413
DOI: doi: 10.1111/aogs.14460
IF: 4.544
Mayorga L, Serrano-Gómez G, Xie Z, Borruel N, Manichanh C
Intercontinental Gut Microbiome Variances in IBD
Int J Mol Sci. 2022 Sep 17;23(18):10868
DOI: doi: 0.3390/ijms231810868
IF: 6.208
Xie Z, Manichanh C
FunOMIC: Pipeline with built-in fungal taxonomic and functional databases for human mycobiome profiling
Comput Struct Biotechnol J. 2022 Jul 11;20:3685-3694
DOI: doi: 10.1016/j.csbj.2022.07.010
IF: 6.155
Oyarzun I, Le Nevé B, Yañez F, Xie Z, Pichaud M, Serrano-Gómez G, Roca J, Veiga P, Azpiroz F, Tap J, Manichanh C
Human gut metatranscriptome changes induced by a fermented milk product are associated with improved tolerance to a flatulogenic diet
Comput Struct Biotechnol J. 2022 Apr 5;20:1632-1641
DOI: doi: 10.1016/j.csbj.2022.04.001
IF: 6.155
Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections
Principal Investigator: Chaysavanh Manichanh
Agency: European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action, Innovative Training Network
Funding: 250,940 €
Period: 2019-2022
Inflammatory Bowel Disease and Microbiome: Diagnosis and prediction of disease activity from the lab to the patients
Principal Investigator: Chaysavanh Manichanh
Agency: Instituto de Salud Carlos III
Funding: 135,520 €
Period: 2021-2023